Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) EBT (2016 - 2025)

Conmed's EBT history spans 16 years, with the latest figure at $29.3 million for Q4 2025.

  • For Q4 2025, EBT fell 32.97% year-over-year to $29.3 million; the TTM value through Dec 2025 reached $71.1 million, down 56.38%, while the annual FY2025 figure was $71.1 million, 56.38% down from the prior year.
  • EBT reached $29.3 million in Q4 2025 per CNMD's latest filing, up from $4.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $56.5 million in Q3 2024 to a low of -$93.5 million in Q2 2022.
  • Average EBT over 5 years is $15.9 million, with a median of $17.4 million recorded in 2021.
  • Peak YoY movement for EBT: crashed 673.96% in 2022, then soared 940.06% in 2024.
  • A 5-year view of EBT shows it stood at $29.6 million in 2021, then crashed by 135.54% to -$10.5 million in 2022, then soared by 486.06% to $40.7 million in 2023, then rose by 7.27% to $43.6 million in 2024, then tumbled by 32.97% to $29.3 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's EBT are $29.3 million (Q4 2025), $4.3 million (Q3 2025), and $29.9 million (Q2 2025).